HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M B Vititnova Selected Research

2- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazole

9/2018On the Mechanism of the Cardioprotective Action of σ1 Receptor Agonist Anxiolytic Fabomotizole Hydrochloride (Afobazole).
6/2017Delayed Results of Experimental Afobazole Therapy in Rats after Acute Myocardial Infarction.
10/2013On the mechanism of anti-ischemic effects of afobazole.
1/2011Study of anti-ischemic effect of afobazole in experimental myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M B Vititnova Research Topics

Disease

5Myocardial Infarction
01/2021 - 01/2011
5Ischemia
09/2019 - 11/2012
4Heart Failure
04/2021 - 06/2017
4Myocardial Ischemia (Ischemic Heart Diseases)
08/2019 - 03/2002
3Alcoholic Cardiomyopathy
05/2021 - 10/2015
2Coronary Occlusion
09/2018 - 11/2013
2Cardiomyopathies (Cardiomyopathy)
07/2016 - 10/2015
1Hyperemia
09/2019
1Hyperhomocysteinemia
08/2019
1Infarction (Infarctions)
09/2018
1Hypertension (High Blood Pressure)
10/2015
1Atrial Fibrillation
01/2010
1Cardiac Arrhythmias (Arrythmia)
05/2003

Drug/Important Bio-Agent (IBA)

42- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazoleIBA
09/2018 - 01/2011
3Proteins (Proteins, Gene)FDA Link
05/2021 - 09/2018
3Isoproterenol (Isoprenaline)FDA LinkGeneric
09/2019 - 10/2013
3Anti-Anxiety Agents (Anxiolytics)IBA
09/2018 - 10/2013
3Ethanol (Ethyl Alcohol)IBA
09/2017 - 10/2015
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
05/2021 - 01/2021
2Messenger RNA (mRNA)IBA
05/2021 - 09/2018
2Doxycycline (Periostat)FDA LinkGeneric
03/2020 - 11/2013
2Metalloproteases (Metalloproteinases)IBA
03/2020 - 11/2013
2Biomarkers (Surrogate Marker)IBA
09/2019 - 09/2018
2N,N- dicyclohexylamide- N'- (3- diethylaminopropyl)- N- (N- nitrobenzoyl) aminoacetic acid hydroxyoxalateIBA
01/2010 - 03/2002
2Anti-Arrhythmia AgentsIBA
01/2010 - 03/2002
1Proline (L-Proline)FDA Link
03/2020
1Adrenergic Receptors (Adrenergic Receptor)IBA
09/2019
1RanolazineFDA Link
08/2019
1Methionine (L-Methionine)FDA Link
08/2019
1Trimetazidine (Vastarel)IBA
08/2019
1Calmodulin (Calcium-Dependent Activator Protein)IBA
09/2018
1GlucocorticoidsIBA
09/2018
1AngiotensinsIBA
09/2018
1RNA (Ribonucleic Acid)IBA
09/2018
1Vasopressins (Vasopressin)IBA
09/2018
1erythromycin propionate-N-acetylcysteinateIBA
09/2018
1Brain Natriuretic Peptide (Natrecor)FDA Link
09/2018
1SolutionsIBA
09/2017
1Vasoconstrictor AgentsIBA
10/2015
1Peptide Hydrolases (Proteases)FDA Link
11/2013
1salicylhydroxamic acid (SHAM)IBA
11/2012
1MorpholinosIBA
01/2011
1PyrazinesIBA
05/2003
1nibentan (HE 11)IBA
03/2002

Therapy/Procedure

2Therapeutics
04/2021 - 06/2017
2Intraperitoneal Injections
01/2021 - 09/2019
2Ligation
11/2013 - 11/2012
1Investigational Therapies (Experimental Therapy)
04/2021